Open access
Open access
Powered by Google Translator Translator

Thu April 30 – 10 Stories of The Day!

30 Apr, 2020 | 04:34h | UTC

 

1 – Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial – The Lancet

Commentaries: First randomized trial of remdesivir suggests antiviral drug is not associated with significant clinical benefits, more research needed – The Lancet AND Expert reaction to trial of remdesivir in adults – Science Media Centre

 

2 – NIH clinical trial shows Remdesivir accelerates recovery from advanced COVID-19 – National Institutes of Health

Commentaries: Hopes rise on coronavirus drug remdesivir – Nature AND The COVID-19 research news rollercoaster is running again: STAT News + Gilead’s remdesivir – HealthNews Review

 

3 – Pooling of samples for testing for SARS-CoV-2 in asymptomatic people – The Lancet Infectious Diseases AND Commentary: Virologists show that sample pooling can massively increase coronavirus testing capacity – Saarland University

Related Preprint Study: Smart Pooled sample Testing for COVID-19: A Possible Solution for Sparsity of Test Kits – medRxiv AND Commentary: ‘Smart sample pooling’ for COVID-19 could solve test kit shortage problem – News Medical

 

4 – Gender Differences in Patients With COVID-19: Focus on Severity and Mortality – Frontiers in Public Health

News Release: COVID-19 study shows that men have over double the death rate of women – Frontiers

 

5 – Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy – New England Journal of Medicine

 

6 – Audio Interview: Loosening Covid-19 Restrictions – New England Journal of Medicine

 

7 – Covid-19 — A Reminder to Reason – New England Journal of Medicine

 

8 – COVID-19 and its implications for thrombosis and anticoagulation – Blood

 

9 – Science Has an Ugly, Complicated Dark Side. And the Coronavirus Is Bringing It Out – Mother Jones

 

10 – Coronavirus Disease (COVID-19) Updates / 30 April 2020 Edition

30 April 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.